NASDAQ:INVO INVO Bioscience (INVO) Stock Price, News & Analysis $1.22 -0.04 (-3.17%) As of 06/20/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About INVO Bioscience Stock (NASDAQ:INVO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get INVO Bioscience alerts:Sign Up Key Stats Today's Range$1.21▼$1.2750-Day Range$1.25▼$2.3352-Week Range$0.63▼$3.50Volume84,559 shsAverage Volume1.59 million shsMarket Capitalization$4.65 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewINVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.Read More… Receive INVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address INVO Stock News HeadlinesINVO Fertility Announces First Quarter 2025 Financial ResultsMay 20, 2025 | globenewswire.comINVO Fertility To Begin Trading Under New Nasdaq Ticker Symbol 'IVF'April 26, 2025 | nasdaq.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. June 22, 2025 | Porter & Company (Ad)NAYA Biosciences to separate fertility and oncology businesses into distinct operations, changes name to INVO FertilityApril 15, 2025 | msn.comNAYA Biosciences announces strategic decision to separate fertility and oncologyApril 15, 2025 | markets.businessinsider.comNAYA Biosciences Changes Name to INVO Fertility Amid Business SeparationApril 14, 2025 | marketwatch.comNAYA Biosciences Inc trading halted, news pendingMarch 18, 2025 | markets.businessinsider.comNAYA Biosciences to effect 1-for-12 reverse splitMarch 13, 2025 | markets.businessinsider.comSee More Headlines INVO Stock Analysis - Frequently Asked Questions How have INVO shares performed this year? INVO Bioscience's stock was trading at $0.81 at the beginning of 2025. Since then, INVO shares have increased by 50.6% and is now trading at $1.22. View the best growth stocks for 2025 here. How were INVO Bioscience's earnings last quarter? INVO Bioscience, Inc. (NASDAQ:INVO) announced its earnings results on Monday, November, 15th. The company reported ($4.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.00) by $0.80. The business had revenue of $0.22 million for the quarter, compared to the consensus estimate of $0.25 million. When did INVO Bioscience's stock split? INVO Bioscience shares reverse split before market open on Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of INVO Bioscience? Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of INVO Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that INVO Bioscience investors own include NVIDIA (NVDA), NIO (NIO), Tesla (TSLA), Meta Platforms (META), Nikola (NKLA), Broadcom (AVGO) and Bilibili (BILI). Company Calendar Last Earnings11/15/2021Today6/21/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:INVO CIK1417926 Webwww.invobioscience.com Phone(978) 878-9505FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$8.03 million Net Margins-122.79% Pretax Margin-122.32% Return on EquityN/A Return on Assets-36.94% Debt Debt-to-Equity RatioN/A Current Ratio0.30 Quick Ratio0.27 Sales & Book Value Annual Sales$5.77 million Price / Sales0.81 Cash FlowN/A Price / Cash FlowN/A Book Value($2.06) per share Price / Book-0.59Miscellaneous Outstanding Shares3,809,000Free Float3,769,000Market Cap$4.65 million OptionableNo Data Beta1.43 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:INVO) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.